1. Home
  2. CALC vs BANL Comparison

CALC vs BANL Comparison

Compare CALC & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • BANL
  • Stock Information
  • Founded
  • CALC 2011
  • BANL 2015
  • Country
  • CALC United States
  • BANL Malaysia
  • Employees
  • CALC N/A
  • BANL N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • BANL Oil Refining/Marketing
  • Sector
  • CALC Health Care
  • BANL Energy
  • Exchange
  • CALC Nasdaq
  • BANL Nasdaq
  • Market Cap
  • CALC 26.7M
  • BANL 25.3M
  • IPO Year
  • CALC N/A
  • BANL 2023
  • Fundamental
  • Price
  • CALC $1.74
  • BANL $0.77
  • Analyst Decision
  • CALC Strong Buy
  • BANL
  • Analyst Count
  • CALC 3
  • BANL 0
  • Target Price
  • CALC $16.33
  • BANL N/A
  • AVG Volume (30 Days)
  • CALC 22.8K
  • BANL 1.3M
  • Earning Date
  • CALC 05-14-2025
  • BANL 04-16-2025
  • Dividend Yield
  • CALC N/A
  • BANL N/A
  • EPS Growth
  • CALC N/A
  • BANL N/A
  • EPS
  • CALC N/A
  • BANL N/A
  • Revenue
  • CALC N/A
  • BANL $592,517,545.00
  • Revenue This Year
  • CALC N/A
  • BANL N/A
  • Revenue Next Year
  • CALC N/A
  • BANL N/A
  • P/E Ratio
  • CALC N/A
  • BANL N/A
  • Revenue Growth
  • CALC N/A
  • BANL 35.93
  • 52 Week Low
  • CALC $1.43
  • BANL $0.55
  • 52 Week High
  • CALC $5.97
  • BANL $1.35
  • Technical
  • Relative Strength Index (RSI)
  • CALC 47.92
  • BANL 37.50
  • Support Level
  • CALC $1.61
  • BANL $0.62
  • Resistance Level
  • CALC $1.73
  • BANL $0.89
  • Average True Range (ATR)
  • CALC 0.10
  • BANL 0.11
  • MACD
  • CALC -0.01
  • BANL -0.02
  • Stochastic Oscillator
  • CALC 33.33
  • BANL 33.84

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: